I consult for various clinical research organizations (CROs) overseeing clinical trials for indications including Alzheimer’s Dementia, Attention Deficit Hyperactivity Disorder (ADHD), Schizophrenia, Bipolar Disorder, Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, Post-Traumatic Stress Disorder, and Acute Suicidality. This includes providing clinical eligibility assessments of patients being screened for trial inclusion; in-study evaluations of patients over the course of the clinical trial; and rater training and remediation. For this, I have received formal training in, and reviewed thousands of protocols for, assessment interviews / instruments including:
- The Structured Clinical Interview for DSM-5 (SCID)
- The MINI Neuropsychiatric Interview
- The Alzheimer’s Disease Assessment Scale (ADAS-COG)
- The Clinical Dementia Rating Scale (CDR)
- The Mini-Mental Status Examination (MMSE)
- The Alzheimer’s Disease Cooperative Study – Activities of Daily Living (ADCS-ADL)
- The Delis-Kaplan Executive Functioning System (D-KEFS)
- The Wechsler Adult Intelligence Scales (WAIS-IV)
- The Wechsler Memory Scales (WMS-IV)
- The Repeatable Battery for the Assessment of Neurocognitive Status (RBANS)
- The Hamilton Rating Scale for Depression (HAM-D)
- The Montgomergy and Asberg Depression Rating Scale (MADRS)
- The Massachusetts General Hospital – Antidepressant Treatment Response Questionnaire
- The Hamilton Rating Scale for Anxiety (HAM-A)
- The Structured Clinical Interview – Positive and Negative Syndrome Scale (SCI-PANSS) and Informant version (IQ-PANSS)
- The Negative Symptom Assessment for Schizophrenia (NSA-16)
- The ADHD Rating Scale
- The ADHD Clinical Diagnostic Scale
- The Liebowitz Social Anxiety Scale (LSAS)